Nonwovens Industry’s Post

Torn or jagged wounds can be particularly challenging to heal. Gladiator Therapeutics can help. Our innovative approach to healing is changing the game in wound care. Don't wait for healing - accelerate it! Explore our range of devices. https://ow.ly/eEHR50RqQG3 #GladiatorTherapeutics #TornWound #JaggedWound #Wound #WoundCare #WoundHealing

The BAFFR-CAR T-cell therapy is being investigated in a phase 1 single-center and phase 1 multicenter trial in B-ALL and B-NHL. https://lnkd.in/egWCTzjt

New video in my youtube channel: Single port SHURUI robotic right lower bronchoplastic lobectomy after chemotherapy and inmunotherapy: https://lnkd.in/ditdySGu

We're still reflecting on the incredible scientific advancements shared in 2023. Dr. Erika Hamilton joined VuMedi to recap #SABCS23 Insights: "CAMBRIA 1 Study of Extended Adjuvant Therapy With Camizestrant vs. Standard ET in Patients With ER+/HER2- Early BC and an Intermediate/High Risk of Recurrence." Watch the full video on VuMedi. https://lnkd.in/eD4pdZqd #ClinicalTrials #OncologyResearch #BCSM #OncologyExpert

What can you do for #glaucoma patients complaining of red, irritated eyes and fluctuating vision? How about those who are noncompliant with their #eyedrops? Glaucoma drug delivery is one avenue to explore. Justin Schweitzer, OD, FAAO from Vance Thompson Vision breaks down how some of the latest technologies, such as Durysta (bimatoprost intracameral implant; AbbVie and iDose TR (travoprost intracameral implant 75 mcg; Glaukos Corporation can help patients manage their glaucoma without the hassle of daily drops. This can be a game-changer for patient compliance and outcomes. #IOP #eyehealth 👁️ Financial Disclosures: AbbVie and Glaukos #ophthalmology #optometry #eyecare #idose #durysta

Eyedropper bottles are difficult to use. In one study, nearly 20% reported difficulties even getting a drop into their eye. How can ophthalmic drug delivery overcome this and improve patient adherence? TTP’s product development consultants Nathan Wilkinson, Catherine Wyman and Matt Parker have sized up the possibilities including new delivery modalities, sustained-release therapeutics, and digital healthcare applications. To learn more, read the full insight: https://lnkd.in/eBjQyAe3 Connect with us at ASCRS to find out more. #ophthalmicdrugdelivery #eyedropper #patientadherence #ASCRS2024

Roche Features 2-Years Analysis from RAINBOWFISH Study of Evrysdi in Children with Spinal Muscular Atrophy at WMS 2024 #roche #evrysdi #Spinalmuscularatrophy #clinicaltrial #wms2024 #sma

Sᴄʟᴇʀᴏsɪɴɢ Cʜᴏʟᴀɴɢɪᴛɪs #PictioREED Look at the ERCP and MRCP findings: multiple strictures and dilatations of the biliary tree In this case, it was secondary to systemic chemotherapy Find out more here: https://lnkd.in/dZKKua3n

⚡ Nivolumab plus platinum-doubletchemotherapy in treatment-naive patientswith advanced grade 3 NeuroendocrineNeoplasms of gastroenteropancreatic orunknown origin: The multicenter phase 2NICE-NEC trial (GETNE-T1913) 🦓 #NeuroendocrineTumors https://buff.ly/46MiN8T

See clearer, live brighter with RAVCARE Digital Therapeutics! Tired of blurry vision? RAVCARE's personalized vision training programs can help improve your visual acuity and overall vision quality. It's like a gym for your eyes! #digitaltherapeutics #visionhealth #bettervision